Cargando…
Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
The COVID-19 pandemic poses an ongoing global challenge, and several risk factors make people with multiple sclerosis (pwMS) particularly susceptible to running a severe disease course. Although the literature does report numerous articles on the risk factors for severe COVID-19 and vaccination resp...
Autores principales: | Immovilli, Paolo, Morelli, Nicola, Terracciano, Chiara, Rota, Eugenia, Marchesi, Elena, Vollaro, Stefano, De Mitri, Paola, Zaino, Domenica, Bazzurri, Veronica, Guidetti, Donata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036272/ https://www.ncbi.nlm.nih.gov/pubmed/35466211 http://dx.doi.org/10.3390/neurolint14020030 |
Ejemplares similares
-
A “Post-mortem” of COVID-19-associated stroke: a case-control study
por: Immovilli, Paolo, et al.
Publicado: (2022) -
The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series
por: Immovilli, Paolo, et al.
Publicado: (2022) -
Guillain-Barré-like axonal polyneuropathy associated with Toscana virus infection: A case report
por: Rota, Eugenia, et al.
Publicado: (2017) -
Migraine and Stroke: “Vascular” Comorbidity
por: Guidetti, Donata, et al.
Publicado: (2014) -
‘Possessed’: Acute Confusional Migraine in an Adolescent, Prevented by Topiramate
por: Rota, Eugenia, et al.
Publicado: (2012)